Cc. Felder et al., ISOLATION AND MEASUREMENT OF THE ENDOGENOUS CANNABINOID RECEPTOR AGONIST, ANANDAMIDE, IN BRAIN AND PERIPHERAL-TISSUES OF HUMAN AND RAT, FEBS letters, 393(2-3), 1996, pp. 231-235
Anandamide (arachidonylethanolamide) is a novel lipid neurotransmitter
first isolated from porcine brain which has been shown to be a functi
onal agonist for the cannabinoid CB1 and CB2 receptors, Anandamide has
never been isolated from human brain or peripheral tissues and its ro
le in human physiology has not been examined, Anandamide was measured
by LC/MS/MS and was found in human and rat hippocampus (and human para
hippocampal cortex), striatum, and cerebellum, brain areas known to ex
press high levels of CB1 cannabinoid receptors, Significant levels of
anandamide were also found in the thalamus which expresses low levels
of CB1 receptors, Anandamide was also found in human and rat spleen wh
ich expresses high levels of the CB2 cannabinoid receptor, Small amoun
ts of anandamide were also detected in human heart and rat skin, Only
trace quantities were detected in pooled human serum, plasma, and CSF,
The distribution of anandamide in human brain and spleen supports its
potential role as an endogenous agonist in central and peripheral tis
sues, The low levels found in serum, plasma, and CSF suggest that it i
s metabolized in tissues where it is synthesized, and that its action
is probably not hormonal in nature.